Press Release – New York, NY –June 6, 2023– Sichenzia Ross Ference LLP announced today that it has represented Jupiter Wellness Acquisition Corp. (“JWAC”), a special purpose acquisition company (a …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp.in $1.7 Million At-The-Market Offering Facility with SciSparc Ltd.
Press Release – New York, NY – May 24, 2023 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. in a $1.7 million At-The-Market offering facility with SciSparc Ltd. …
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $5.0 Million Private Placement Priced At-the-Market
Press Release – New York, NY – May 16, 2023 – Sichenzia Ross Ference LLP announced today that it represented Sunshine BioPharma, Inc. (Nasdaq: SBFM) (the “Company”), a pharmaceutical company offering …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering
Press Release – New York, NY – May 11, 2023 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp., (NASDAQ: “LEXX”), a global innovator in drug delivery platforms, …
Sichenzia Ross Ference LLP Represents Zynex, Inc. in $60 Million 144A Private Offering of Convertible Notes
Press Release – New York, NY – May 11, 2023 – Sichenzia Ross Ference LLP announced today that it represented Zynex, Inc., (“The Company”) (NASDAQ: “ZYXI”) an innovative medical technology company …
Sichenzia Ross Ference LLP Represents Wang & Lee Group, Inc. in $8 Million Initial Public Offering of Ordinary Shares
Press Release – New York, NY –April 25, 2023 – Sichenzia Ross Ference LLP announced today that it represented Wang & Lee Group, Inc. in an $8 million initial public offering of ordinary shares …
